Man takes 217 COVID vaccines with no ill effects, shows immune boost

FHS
March 8, 2024
3:30 am

A case report of a 62-year-old man receiving 217 SARS-CoV-2 vaccinations over 29 months reveals no adverse effects, increased T-cells, and spike-specific antibodies, providing unique insights into the effects of hyper-vaccination on immune responses.

J&J to face pivotal hearing over its $8B talc settlement plan

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 15, 2025

Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused

October 31, 2023

Bernie Sanders invites CEOs of J&J, Merck, Bristol Myers to testify on drug pricing

Senate Health Committee Chair Bernie Sanders (I-VT) and fellow Democrats on Tuesday announced that the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb

November 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.